These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1347 related items for PubMed ID: 19054552

  • 1. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
    Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB.
    Lancet; 2009 Feb 07; 373(9662):482-91. PubMed ID: 19054552
    [Abstract] [Full Text] [Related]

  • 2. Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials.
    Lockley SW, Dressman MA, Licamele L, Xiao C, Fisher DM, Flynn-Evans EE, Hull JT, Torres R, Lavedan C, Polymeropoulos MH.
    Lancet; 2015 Oct 31; 386(10005):1754-64. PubMed ID: 26466871
    [Abstract] [Full Text] [Related]

  • 3. Tasimelteon: a melatonin receptor agonist for non-24-hour sleep-wake disorder.
    Johnsa JD, Neville MW.
    Ann Pharmacother; 2014 Dec 31; 48(12):1636-41. PubMed ID: 25204464
    [Abstract] [Full Text] [Related]

  • 4. Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia.
    van der Heijden KB, Smits MG, van Someren EJ, Boudewijn Gunning W.
    J Sleep Res; 2005 Jun 31; 14(2):187-94. PubMed ID: 15910516
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tasimelteon for the treatment of non-24-hour sleep-wake disorder.
    Neubauer DN.
    Drugs Today (Barc); 2015 Jan 31; 51(1):29-35. PubMed ID: 25685859
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of Tasimelteon (HETLIOZ®) in the Treatment of Jet Lag Disorder Evaluated in an 8-h Phase Advance Model; a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
    Polymeropoulos CM, Mohrman MA, Keefe MS, Brzezynski JL, Wang J, Prokosch LS, Polymeropoulos VM, Xiao C, Birznieks G, Polymeropoulos MH.
    Front Neurol; 2020 Jan 31; 11():611. PubMed ID: 32754110
    [Abstract] [Full Text] [Related]

  • 11. Melatonin treatment effects on adolescent students' sleep timing and sleepiness in a placebo-controlled crossover study.
    Eckerberg B, Lowden A, Nagai R, Akerstedt T.
    Chronobiol Int; 2012 Nov 31; 29(9):1239-48. PubMed ID: 23005039
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL, Magee M, Murray JM, Gordon CJ, Lovato N, Kennaway DJ, Gwini SM, Bartlett DJ, Lockley SW, Lack LC, Grunstein RR, Rajaratnam SMW, Delayed Sleep on Melatonin (DelSoM) Study Group.
    PLoS Med; 2018 Jun 31; 15(6):e1002587. PubMed ID: 29912983
    [Abstract] [Full Text] [Related]

  • 13. Circadian phase, sleepiness, and light exposure assessment in night workers with and without shift work disorder.
    Gumenyuk V, Roth T, Drake CL.
    Chronobiol Int; 2012 Aug 31; 29(7):928-36. PubMed ID: 22823876
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind.
    Emens JS, Eastman CI.
    Drugs; 2017 Apr 31; 77(6):637-650. PubMed ID: 28229310
    [Abstract] [Full Text] [Related]

  • 16. Melatonin decreases daytime challenging behaviour in persons with intellectual disability and chronic insomnia.
    Braam W, Didden R, Maas AP, Korzilius H, Smits MG, Curfs LM.
    J Intellect Disabil Res; 2010 Jan 01; 54(1):52-9. PubMed ID: 19888921
    [Abstract] [Full Text] [Related]

  • 17. Tasimelteon for treating non-24-h sleep-wake rhythm disorder.
    Nishimon S, Nishimon M, Nishino S.
    Expert Opin Pharmacother; 2019 Jun 01; 20(9):1065-1073. PubMed ID: 30990759
    [Abstract] [Full Text] [Related]

  • 18. Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia.
    Hajak G, Rodenbeck A, Adler L, Huether G, Bandelow B, Herrendorf G, Staedt J, Rüther E.
    Pharmacopsychiatry; 1996 Sep 01; 29(5):187-92. PubMed ID: 8895944
    [Abstract] [Full Text] [Related]

  • 19. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia.
    Van der Heijden KB, Smits MG, Van Someren EJ, Ridderinkhof KR, Gunning WB.
    J Am Acad Child Adolesc Psychiatry; 2007 Feb 01; 46(2):233-41. PubMed ID: 17242627
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.